Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1749.9 Million | USD 2906.1 Million | 5.92% | 2023 |
According to Zion Market Research, the global Nocturia Market was worth USD 1749.9 Million in 2023. The market is forecast to reach USD 2906.1 Million by 2032, growing at a compound annual growth rate (CAGR) of 5.92% during the forecast period 2024-2032.
The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Nocturia industry over the next decade.
Experiencing frequent urge of urination during the night after sleeping is a medical condition that is termed as nocturia or nocturnal polyuria. This happens among the aged patients and sleep deficiency can often lead to nocturia. The women that are between 18 to 49 years have more chances of having nocturia than men, the percentage reverses after the age of 60. Other reasons that cause nocturia are depression, mental stress, low level of physical activities, and congestive heart failure.
Report Attributes | Report Details |
---|---|
Report Name | Nocturia Market |
Market Size in 2023 | USD 1749.9 Million |
Market Forecast in 2032 | USD 2906.1 Million |
Growth Rate | CAGR of 5.92% |
Number of Pages | 110 |
Key Companies Covered | Allergan, Inc., Vantia Therapeutics, Astellas Pharma Inc., Urigen Pharmaceuticals, Inc., and Dainippon Sumitomo Pharma Co., Ltd |
Segments Covered | By Types, By Causes And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global nocturia market is segmented into its types, causes, and regions.
On the basis of types, the market is segregated into mixed nocturia, bladder storage problems, and nocturnal polyuria.
Based on the causes, the market is categorized into urological infection, a tumor of the bladder, diuretic medications, regular alcohol or coffee, liver infection, diabetes, pregnancy, and others.
The geographical segmentation of the global nocturia market includes North America, Asia Pacific, Europe, and Rest of the World.
For the proper cure of nocturia, diagnosis to cardiac symptoms, identification of neurological disorders, hypertension, and intake of medicines such as cardiac glycosides should be appropriate, thus awareness about the condition has increased. A thorough examination of the patients should be done to diagnose for sleep apnea, lower limb edema, obesity, and pelvic analysis. The diagnostics segment of the nocturia market will maintain a consistent demand as the population of the aged people is increasing across the global.
According to the study conducted by the National Institute of Aging around 1.6 billion of the population will be aged over 65 by 2050. Surgical intervention with respect to transurethral prostatectomy and pelvic organ prolapse repair are the final approaches for surgeons and physicians. In past couple of years, nocturia has gained a lot of attention owing to its increased cases has prompted researches and manufacturers to make investments thereby improving quality sleep and on the whole increasing the life rating. Some of the drugs that are pipelined include desmopressin acetate, fedovapagon, afacifenacin, ASP-7035, Paxerol, lidocaine, among others.
Due to the sophisticated healthcare infrastructure in the countries such as US and Canada the North American region has emerged as the most lucrative region in the global market for nocturia. Europe too is experiencing a positive approach owing to the feasible support, rising aging population, and sponsorship from government agencies and private companies. Asia-Pacific and other regional markets are also growing in the nocturia market owing to the rise in the research activities thus contributing significantly in the global nocturia market. For the new market players and the existing ones, these regions provide a pool of opportunities to grow and explore in this field owing to rise in disposable income, developments in healthcare infrastructure, and increasing incidences of bladder cancer and diabetes conditions.
Some of the key market players that are involved in the nocturia market include
Global Nocturia Market: Types Segment Analysis
Global Nocturia Market: Causes Segment Analysis
Global Nocturia Market: Regional Segment Analysis
FrequentlyAsked Questions
Experiencing frequent urge of urination during the night after sleeping is a medical condition that is termed as nocturia or nocturnal polyuria.
For the proper cure of nocturia, diagnosis to cardiac symptoms, identification of neurological disorders, hypertension, and intake of medicines such as cardiac glycosides should be appropriate, thus awareness about the condition has increased.
According to a study, the global nocturia Industry size was $1749.9 Million in 2023 and is projected to reach $2906.1 Million by the end of 2032.
The global nocturia market is expected to grow at a CAGR of 5.92% during the forecast period.
Some of the key market players that are involved in the nocturia market include Allergan, Inc., Vantia Therapeutics, Astellas Pharma Inc., Urigen Pharmaceuticals, Inc., and Dainippon Sumitomo Pharma Co., Ltd.
The global nocturia market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed